Clinical Trial Update: An Open Label Study to Evaluate the Tolerability and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in Combination With Cyclosporine Microemulsion (CsA-ME) in Maintenance Renal Transplant Recipients [Phase 3]

View source ↗

Summary

This open-label Phase 3 study evaluated the tolerability and safety of enteric-coated mycophenolate sodium in combination with cyclosporine microemulsion in mai…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Cyclosporine microemulsion (CsA-ME) (cyclosporine)
• Mycophenolate sodium (EC-MPS) (mycophenolate sodium)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Kidney Transplant Recipients | Phase 3 | Status: COMPLETED